Controlled-Release Oxycodone and Naloxone in the Treatment of Chronic Low Back Pain: A Placebo-Controlled, Randomized Study
BACKGROUND: For Canadian regulatory purposes, an analgesic study was required to complement previously completed, pivotal studies on bowel effects and analgesia associated with controlled-release (CR) oxycodone/CR naloxone.
Saved in:
Main Authors: | C Cloutier, J Taliano, W O’Mahony, M Csanadi, G Cohen, I Sutton, D Sinclair, M Awde, S Henein, L Robinson, J Eisenhoffer, PS Piraino, Z Harsanyi, KJ Michalko |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2013/164609 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pain and Sleep Questionnaire Three-Item Index (PSQ-3): A Reliable and Valid Measure of The Impact of Pain on Sleep in Chronic Nonmalignant Pain of Various Etiologies
by: Lindsay E Ayearst, et al.
Published: (2012-01-01) -
Role of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain
by: Yinxia Wang, et al.
Published: (2020-01-01) -
Insights from a Pilot Study of Naloxone Education
Published: (2019-12-01) -
When Should Naloxone Be Administered to the Undifferentiated Unresponsive Person?
Published: (2018-08-01) -
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial
by: Jason M Glanz, et al.
Published: (2024-04-01)